ZA952841B - Oxopyridinylquinoxaline derivative - Google Patents

Oxopyridinylquinoxaline derivative

Info

Publication number
ZA952841B
ZA952841B ZA952841A ZA952841A ZA952841B ZA 952841 B ZA952841 B ZA 952841B ZA 952841 A ZA952841 A ZA 952841A ZA 952841 A ZA952841 A ZA 952841A ZA 952841 B ZA952841 B ZA 952841B
Authority
ZA
South Africa
Prior art keywords
lower alkyl
substituted
nitro
halogen
hydrogen
Prior art date
Application number
ZA952841A
Other languages
English (en)
Inventor
Sasumu Takada
Nobuo Chomei
Makoto Adachi
Masami Eigyo
Kazuo Kawasaki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ZA952841B publication Critical patent/ZA952841B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA952841A 1994-04-08 1995-04-06 Oxopyridinylquinoxaline derivative ZA952841B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7090994 1994-04-08

Publications (1)

Publication Number Publication Date
ZA952841B true ZA952841B (en) 1995-12-18

Family

ID=13445121

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952841A ZA952841B (en) 1994-04-08 1995-04-06 Oxopyridinylquinoxaline derivative

Country Status (14)

Country Link
US (1) US5677305A (da)
EP (1) EP0676397B1 (da)
KR (1) KR100363003B1 (da)
CN (1) CN1044241C (da)
AT (1) ATE185806T1 (da)
AU (1) AU688459B2 (da)
CA (1) CA2146478A1 (da)
DE (1) DE69512816T2 (da)
DK (1) DK0676397T3 (da)
ES (1) ES2140620T3 (da)
GR (1) GR3032406T3 (da)
HU (1) HUT72064A (da)
TW (1) TW300894B (da)
ZA (1) ZA952841B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
AUPN842196A0 (en) * 1996-03-05 1996-03-28 Fujisawa Pharmaceutical Co., Ltd. New compound
AU744540B2 (en) * 1997-09-01 2002-02-28 Kyorin Pharmaceutical Co. Ltd. 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
WO1999062887A1 (en) 1998-06-01 1999-12-09 Shionogi & Co., Ltd. Cyanoiminoquinoxaline derivatives
EP1904481B1 (en) * 2005-06-23 2016-02-17 Array Biopharma, Inc. Process for preparing benzimidazole compounds
WO2010053757A1 (en) 2008-10-29 2010-05-14 Gilead Palo Alto, Inc. 2 -oxoquinoxalin blockers of the late sodium channel
US20100113514A1 (en) 2008-10-30 2010-05-06 Gilead Palo Alto, Inc. Fused heterocyclic compounds as ion channel modulators
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
CN103664806B (zh) * 2013-12-16 2016-06-29 山东汇海医药化工有限公司 一种n-乙酰乙酰基-6-甲氧基-7-氨基喹喔啉-2，3-二酮的制备方法
WO2018158160A1 (en) 2017-02-28 2018-09-07 Universitat Autonoma De Barcelona (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies
WO2019161917A1 (en) 2018-02-23 2019-08-29 Universitat Autonoma De Barcelona 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies
WO2024083850A1 (en) 2022-10-18 2024-04-25 ETH Zürich Electrocatalyst

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
JP2635662B2 (ja) * 1987-03-23 1997-07-30 ノボ・ノルデイスク・アクツイエルスカブ ヘテロ環状化合物，その製造方法及びその使用法
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
US5153195A (en) * 1988-12-22 1992-10-06 Novo Nordisk A/S Quinoxaline compounds and their preparation and use
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK0556393T3 (da) * 1990-11-06 2000-10-16 Yamanouchi Pharma Co Ltd Tilkondenseret pyrazinderivat
JPH04193876A (ja) * 1990-11-26 1992-07-13 Sumitomo Chem Co Ltd キノキザリン誘導体、その製造法およびそれを有効成分とする除草剤
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
JPH06228112A (ja) * 1993-02-05 1994-08-16 Yamanouchi Pharmaceut Co Ltd （１ｈ，４ｈ）キノキサリン誘導体
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative

Also Published As

Publication number Publication date
HUT72064A (en) 1996-03-28
AU1625695A (en) 1995-10-19
CA2146478A1 (en) 1995-10-09
DE69512816T2 (de) 2000-04-27
DE69512816D1 (de) 1999-11-25
KR950032171A (ko) 1995-12-20
EP0676397A1 (en) 1995-10-11
US5677305A (en) 1997-10-14
GR3032406T3 (en) 2000-05-31
EP0676397B1 (en) 1999-10-20
TW300894B (da) 1997-03-21
AU688459B2 (en) 1998-03-12
DK0676397T3 (da) 2000-04-03
CN1123792A (zh) 1996-06-05
HU9501026D0 (en) 1995-06-28
CN1044241C (zh) 1999-07-21
KR100363003B1 (ko) 2003-02-11
ATE185806T1 (de) 1999-11-15
ES2140620T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
NO913750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
MY113733A (en) Salts of an anti-migraine indole derivative
TW427996B (en) Novel triazolopyrimidines and their use as medicaments
AU563683C (en) Substituted acyl derivative of 1,2,3,4-tetrahydroiso- quinoline-3-carboxylic acid
DE69120100T2 (de) Annelierte Thiophen-Derivate, ihre Herstellung und Verwendung
EP0989129A4 (en) PYRAZOLOPYRIDYLPYRIDAZINONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
AU5752194A (en) Benzimidazole compounds, their use and preparation
EP0767170A4 (en) 4,6-DIARYLPYRIMIDINE DERIVATIVES AND THEIR SALTS
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
HU9501026D0 (en) Oxopyridinylquinoxaline derivative
WO1999024022A3 (en) Isoquinoline derivatives for treating disorders associated with 5ht7 receptors
CA2119662A1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL339143A1 (en) Tetrahydro-gamma-carbolynes
CA2135783A1 (en) Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation
WO1996005166A1 (fr) Derive d'amine substitue et composition medicamenteuse le contenant
WO2002094770A3 (en) Aminoalcohol derivatives
EP1034783A4 (en) AMIDE DERIVATIVES
TW280819B (da)
GR3020271T3 (en) (Benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma
WO1999038841A8 (en) Adamantanecarboximidamide derivatives and their use as nmda antagonists
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
ES2002325A6 (es) Un procedimiento para preparar un derivado de dihidropiridina